A Utah study says AI-assisted monitoring cut hospitalizations in half for patients with COPD and asthma. The system watched for warning signs between clinic visits.

The Chickasaw Nation has launched a $1 billion medical campus in Newcastle, with 5,500 jobs and millions of square feet planned. The project could transform health care and infrastructure across the southwest Oklahoma City metro.

Roblox shares plunged as safety changes weighed on engagement and the company offered a sharply weaker bookings forecast. The San Mateo gaming giant is betting investors will wait for the long-term payoff.

A Boyle Heights mother won a temporary court order keeping her daughter on life support after doctors declared her brain dead.

San Francisco-based DoorDash is facing a House inquiry over its use of Chinese AI models for some workloads. The probe adds national-security pressure to a cost-saving strategy spreading through Silicon Valley.

A Chicago-led IBM and University of Chicago experiment claims a quantum advantage milestone with 70 logical qubits and built-in error verification.

Resilience and Eli Lilly are putting $750 million into Cincinnati-area medicine manufacturing, with at least 400 new jobs on the way. KwikPen production is expected to begin in early 2027.

Louisville Metro EMS has reached its 100th pre-hospital whole-blood transfusion, marking a major milestone for the city's trauma response.

OhioHealth’s new Columbus clinic is built to shorten the anxious wait after a concerning scan, lab result or symptom.

A six-month-old Alaska baby became the youngest CHOP patient to receive gene therapy for metachromatic leukodystrophy. His case underscores the race to diagnose MLD before symptoms begin.

Bloom Security, founded by Palo Alto Networks veterans, has raised $20 million to secure AI-heavy employee endpoints. Its platform tracks the tools and agents traditional security stacks can miss.

Microsoft may open parts of its homegrown AI stack as cheaper Chinese models gain traction among U.S. users.

A Wistar-led study traces ovarian cancer’s chemotherapy resistance to an inflammatory chain involving IL-1β, neutrophils and tumor-protecting traps.